|
1
|
de Paulsen N, Brychzy A, Fournier MC, et
al: Role of transforming growth factor-alpha in von Hippel-Lindau
(VHL)(−/−) clear cell renal carcinoma cell proliferation: a
possible mechanism coupling VHL tumor suppressor inactivation and
tumorigenesis. Proc Natl Acad Sci USA. 98:1387–1392. 2001.
|
|
2
|
Vanharanta S, Shu W, Brenet F, et al:
Epigenetic expansion of VHL-HIF signal output drives multiorgan
metastasis in renal cancer. Nat Med. 19:50–56. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kapitsinou PP and Haase VH: The VHL tumor
suppressor and HIF: insights from genetic studies in mice. Cell
Death Differ. 15:650–659. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gong K, Zhang N, Zhang K and Na Y: The
relationship of erythropoietin overexpression with von
Hippel-Lindau tumour suppressor gene mutations between
hypoxia-inducible factor-1α and -2α in sporadic clear cell renal
carcinoma. Int J Mol Med. 26:907–912. 2010.PubMed/NCBI
|
|
5
|
Minet E, Michel G, Remacle J and Michiels
C: Role of HIF-1 as a transcription factor involved in embryonic
development, cancer progression and apoptosis (Review). Int J Mol
Med. 5:253–259. 2000.PubMed/NCBI
|
|
6
|
Shen G, Li X, Jia YF, Piazza GA and Xi Y:
Hypoxia-regulated microRNAs in human cancer. Acta Pharmacol Sin.
34:336–341. 2013. View Article : Google Scholar
|
|
7
|
Chan YC, Banerjee J, Choi SY and Sen CK:
miR-210: the master hypoxamir. Microcirculation. 19:215–223. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chan SY and Loscalzo J: MicroRNA-210: a
unique and pleiotropic hypoxamir. Cell Cycle. 9:1072–1083. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Neal CS, Michael MZ, Rawlings LH, Van der
Hoek MB and Gleadle JM: The VHL-dependent regulation of microRNAs
in renal cancer. BMC Med. 8:642010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang W, Sun T, Cao J, Liu F, Tian Y and
Zhu W: Downregulation of miR-210 expression inhibits proliferation,
induces apoptosis and enhances radiosensitivity in hypoxic human
hepatoma cells in vitro. Exp Cell Res. 318:944–954. 2012.
View Article : Google Scholar
|
|
11
|
Fasanaro P, Greco S, Lorenzi M, et al: An
integrated approach for experimental target identification of
hypoxia-induced miR-210. J Biol Chem. 284:35134–35143. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tsuchiya S, Fujiwara T, Sato F, et al:
MicroRNA-210 regulates cancer cell proliferation through targeting
fibroblast growth factor receptor-like 1 (FGFRL1). J Biol Chem.
286:420–428. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ying Q, Liang L, Guo W, et al:
Hypoxia-inducible microRNA-210 augments the metastatic potential of
tumor cells by targeting vacuole membrane protein 1 in
hepatocellular carcinoma. Hepatology. 54:2064–2075. 2011.
View Article : Google Scholar
|
|
14
|
Ropolo A, Grasso D, Pardo R, et al: The
pancreatitis-induced vacuole membrane protein 1 triggers autophagy
in mammalian cells. J Biol Chem. 282:37124–37133. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sauermann M, Sahin O, Sültmann H, et al:
Reduced expression of vacuole membrane protein 1 affects the
invasion capacity of tumor cells. Oncogene. 27:1320–1326. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ozdemir F, Altinisik J, Karateke A,
Coksuer H and Buyru N: Methylation of tumor suppressor genes in
ovarian cancer. Exp Ther Med. 4:1092–1096. 2012.PubMed/NCBI
|
|
17
|
Osada R, Horiuchi A, Kikuchi N, et al:
Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible
factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian
neoplasms and allelic loss of von Hippel-Lindau gene: nuclear
expression of hypoxia-inducible factor 1alpha is an independent
prognostic factor in ovarian carcinoma. Hum Pathol. 38:1310–1320.
2007.
|
|
18
|
Semenza GL: HIF-1 and tumor progression:
pathophysiology and therapeutics. Trends Mol Med. 8(Suppl 4):
S62–S67. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rothe F, Ignatiadis M, Chaboteaux C, et
al: Global microRNA expression profiling identifies MiR-210
associated with tumor proliferation, invasion and poor clinical
outcome in breast cancer. PLoS One. 6:e209802011. View Article : Google Scholar
|
|
20
|
Redova M, Poprach A, Besse A, et al:
MiR-210 expression in tumor tissue and in vitro effects of its
silencing in renal cell carcinoma. Tumour Biol. 34:481–491. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Giannakakis A, Sandaltzopoulos R, Greshock
J, et al: miR-210 links hypoxia with cell cycle regulation and is
deleted in human epithelial ovarian cancer. Cancer Biol Ther.
7:255–264. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Guo L, Yang LY, Fan C, Chen GD and Wu F:
Novel roles of Vmp1: inhibition metastasis and proliferation of
hepatocellular carcinoma. Cancer Sci. 103:2110–2119. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu F, Niu Y, Liu N, et al: Expression of
vacuole membrane protein 1 and its prognostic value in invasive
ductal carcinoma of the breast. Zhonghua Bing Li Xue Za Zhi.
42:86–89. 2013.(In Chinese).
|
|
24
|
Moch H: Von-Hippel-Lindau (VHL) protein
function by initiation and progression of renal cancer. Pathologe.
29(Suppl 2): 149–152. 2008.(In German).
|
|
25
|
Ivanov SV, Ivanova AV, Salnikow K,
Timofeeva O, Subramaniam M and Lerman MI: Two novel VHL targets,
TGFBI (BIGH3) and its transactivator KLF10, are up-regulated in
renal clear cell carcinoma and other tumors. Biochem Biophys Res
Commun. 370:536–540. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yu F, White SB, Zhao Q and Lee FS:
HIF-1alpha binding to VHL is regulated by stimulus-sensitive
proline hydroxylation. Proc Natl Acad Sci USA. 98:9630–9635. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kaelin WG Jr: The von Hippel-Lindau
protein, HIF hydroxylation, and oxygen sensing. Biochem Biophys Res
Commun. 338:627–638. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Semenza GL: Targeting HIF-1 for cancer
therapy. Nat Rev Cancer. 3:721–732. 2003. View Article : Google Scholar
|
|
29
|
Zia MK, Rmali KA, Watkins G, Mansel RE and
Jiang WG: The expression of the von Hippel-Lindau gene product and
its impact on invasiveness of human breast cancer cells. Int J Mol
Med. 20:605–611. 2007.PubMed/NCBI
|
|
30
|
Choueiri TK, Fay AP, Gagnon R, et al: The
role of aberrant VHL/HIF pathway elements in predicting clinical
outcome to pazopanib therapy in patients with metastatic clear-cell
renal cell carcinoma. Clin Cancer Res. 19:5218–5226. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mace TA, Collins AL, Wojcik SE, Croce CM,
Lesinski GB and Bloomston M: Hypoxia induces the overexpression of
microRNA-21 in pancreatic cancer cells. J Surg Res. 2:855–860.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Crosby ME, Kulshreshtha R, Ivan M and
Glazer PM: MicroRNA regulation of DNA repair gene expression in
hypoxic stress. Cancer Res. 69:1221–1229. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Camps C, Buffa FM, Colella S, et al:
hsa-miR-210 is induced by hypoxia and is an independent prognostic
factor in breast cancer. Clin Cancer Res. 14:1340–1348. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Feng Y, Zhang S and Huang X: A robust
TALENs system for highly efficient mammalian genome editing. Sci
Rep. 4:36322014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu Y, Han Y, Zhang H, et al: Synthetic
miRNA-mowers targeting miR-183–96–182 cluster or miR-210 inhibit
growth and migration and induce apoptosis in bladder cancer cells.
PLoS One. 7:e522802012.PubMed/NCBI
|
|
36
|
Cui H, Grosso S, Schelter F, Mari B and
Kruger A: On the pro-metastatic stress response to cancer
therapies: evidence for a positive co-operation between TIMP-1,
HIF-1α, and miR-210. Front Pharmacol. 3:1342012.PubMed/NCBI
|
|
37
|
Huang X, Ding L, Bennewith KL, et al:
Hypoxia-inducible mir-210 regulates normoxic gene expression
involved in tumor initiation. Mol Cell. 35:856–867. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Evans AJ, Russell RC, Roche O, et al: VHL
promotes E2 box-dependent E-cadherin transcription by HIF-mediated
regulation of SIP1 and snail. Mol Cell Biol. 27:157–169. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Esteban MA, Tran MG, Harten SK, et al:
Regulation of E-cadherin expression by VHL and hypoxia-inducible
factor. Cancer Res. 66:3567–3575. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhou Q, Chen T, Ibe JC, Raj JU and Zhou G:
Knockdown of von Hippel-Lindau protein decreases lung cancer cell
proliferation and colonization. FEBS Lett. 586:1510–1515. 2012.
View Article : Google Scholar : PubMed/NCBI
|
